US 12012468
Cyclic polypeptides for PCSK9 inhibition
granted A61KA61K38/00A61P
Quick answer
US patent 12012468 (Cyclic polypeptides for PCSK9 inhibition) held by RA PHARMACEUTICALS, INC. expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P3/06, A61P9/10